Designing information for lung cancer patients in decision making.

Treatment of stage I non-small cell lung cancer: designing information for patient participation in decision making.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21162

Enrollment

Registered

2012-01-17

Start date

2012-01-30

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients presenting with a stage I non-small cell lung cancer (NSCLC). Patienten met stadium I niet kleincellige longkanker.

Interventions

Descriptive qualitative study using semi-structured cognitive interviews.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients with early stage lung cancer who are scheduled to undergo SABR treatment; 2. Written informed consent according to local medical ethical committee regulations.

Exclusion criteria

Exclusion criteria: 1. Patients who are unable to speak and understand the Dutch or English language; 2. Patients who are unable to provide informed consent.

Design outcomes

Primary

Measure	Time frame
Usability.	—

Contacts

Public ContactW. Hopmans

Van der Boechorststraat 7

w.hopmans@vumc.nl+31 (0)20 4449067

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)